FFG
REGN icon

Fortem Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Fortem Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-819
Closed -$591K – 161
2022
Q4 		$591K Hold
819
– – 0.35% 87
2022
Q3 		$564K Sell
819
-160
-16% -$101K 0.39% 79
2022
Q2 		$579K Sell
979
-3,702
-79% -$2.41M 0.38% 86
2022
Q1 		$3.27M Buy
4,681
+800
+21% +$506K 1.43% 14
2021
Q4 		$2.45M Buy
3,881
+42
+1% +$25.8K 1.12% 28
2021
Q3 		$2.32M Buy
3,839
+106
+3% +$65.8K 1.18% 24
2021
Q2 		$2.08M Buy
3,733
+1,296
+53% +$657K 1.06% 28
2021
Q1 		$1.15M Buy
2,437
+62
+3% +$30.2K 0.67% 58
2020
Q4 		$1.15M Sell
2,375
-124
-5% -$66.9K 0.69% 47
2020
Q3 		$1.4M Buy
+2,499
New +$1.52M 1.01% 34

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return